🔥 Trending Dean Ho: The NUS Professor Who Became His Own Test Subject in a Groundbreaking L

Dean Ho is a distinguished biomedical engineer and pharmacologist, currently serving as a Provost's Chair Professor at the National University of Singapore (NUS) ⁸. He is also the director of the Institute for Digital Medicine (WisDM) at NUS Medicine ⁴. Ho is widely recognized for his work in artificial intelligence (AI), digital medicine, and their applications in optimizing health and performance, particularly in the realm of longevity ¹⁸.

Dean Ho's Groundbreaking Longevity Study: The DELTA Trial

Professor Dean Ho gained significant attention for his unique and highly personalized longevity study known as the DELTA Trial ²⁴. What makes this study particularly groundbreaking is that Professor Ho became the sole subject of his own research ⁴⁵.

Study Design and Methodology

The DELTA Trial, launched by Ho and his team, is described as a "first-in-kind human trial" ⁵. It employs an N-of-1 protocol, meaning it focuses on a single individual to deeply analyze the effects of various interventions. The study integrates a combination of advanced techniques:

• Artificial Intelligence (AI): AI plays a crucial role in analyzing data and guiding interventions ²⁵.
• Digital Medicine: Various digital health platforms are utilized for monitoring and data collection ⁵.
• Fasting: Specific fasting protocols are part of the intervention strategy ⁵.
• Fitness: Tailored fitness regimens are incorporated ⁵.
• Food: Dietary adjustments are made to optimize metabolic health ⁵.

The primary goal of these combined interventions is to optimize metabolic health and explore aspects of healthspan ¹⁵.

Key Findings and Impact

The early results of the DELTA Trial have been published in a peer-reviewed article in PNAS Nexus ¹. The study's findings indicate significant improvements in Professor Ho's health. Notably, by using his own data to guide these interventions, Professor Ho achieved a metabolic age that is 14 years younger than his chronological age ⁷.

One of the significant discoveries from the DELTA Trial is the identification of the GRIT biomarker ². This biomarker is described as a powerful and accessible tool designed to quantify resilience and provide guidance for improving human performance ².

Broader Implications

Professor Ho's work, particularly the DELTA Trial, highlights the potential of personalized medicine and the integration of AI with lifestyle interventions to impact longevity and healthspan ¹⁷. His research contributes to the growing understanding of how individual data can be leveraged to create customized health optimization strategies. He frequently speaks at international conferences on longevity, AI, and healthspan, sharing insights from the DELTA Trial ¹.